Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBOT Biomarker Dynamics in Veterans With TBI and PCS
NCT07849465Phase 2Recruiting
- Sponsor
- Summit Hyperbarics and Wellness
- Start
- Oct 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
Phase 2, open-label trial in traumatic brain injury (TBI) and Post-concussion syndrome (PCS), sponsored by Summit Hyperbarics and Wellness. Primary endpoints: C-reactive protein at 4 weeks, Interleukin-1 at 4 weeks and 6 more. Started Oct 2026; status: recruiting.
02
Conditions
traumatic brain injury (TBI)Post-concussion syndrome (PCS)
Beyond the preview
Go deeper on NCT07849465.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07849465.